The Global Health Body Issues Alert Over Severe Lack of Obesity Jabs
Less than a tenth of patients that would benefit from GLP-1 drugs including Wegovy are able to get them, warns the global health agency as it publishes its first advice on the drugs.
Given more than one billion people worldwide currently living with obesity, it is urging more widespread and fairer access to these injectable treatments.
According to forecasts, over two billion are projected to be obese by 2030 unless action is taken.
"The latest guidelines affirms that obesity is a lifelong illness that can be treated with comprehensive and ongoing support," said the agency's head Tedros Adhanom Ghebreyesus.
Significant expense, limited production capacity, and supply-chain constraints are significant hurdles to broad access to the treatments that can aid individuals in losing substantial body mass, explains the organization.
Skinny Jab Shortage
Despite the current most optimistic outlook, the production of these medications would only suffice for around 100 million people – under 10% of the global need, as stated by the WHO.
The recommendation encourages nations and manufacturers to increase access, by approaches such as voluntary licensing.
The intellectual property rights on a key compound – the core ingredient of a leading brand – is due to expire in multiple nations in 2026.
The Way Weight-Loss Injections Operate
The injections mimick a natural hormone to reduce digestion speed, reduce hunger and enhance satiety so people eat less.
Patients commonly start to lose weight within a few weeks of beginning the once-weekly jabs.
Research points to users may regain a significant portion after a year of discontinuing the drug, because their typical hunger return.
To be carrying excess weight increases your likelihood for experiencing health problems, such as type 2 diabetes, cardiovascular issues, brain attack, and some malignancies.
Obesity concerns people in every country and was responsible for 3.7 million deaths worldwide in 2024, according to the WHO.
